Domínguez-Carral Jana, Reinhard Carola, Yoo Jane, Soliani Luca, Cif Laura, Ortigoza-Escobar Juan Darío
Epilepsy Unit, Department of Child Neurology, Coordinating member of the ERN EpiCARE, Hospital Sant Joan de Déu, Universitat de Barcelona, Barcelona, Spain.
Institute for Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany; Centre for Rare Diseases, University Hospital Tübingen, Tübingen, Germany; European Reference Network for Rare Neurological Diseases, Tübingen, Germany.
Neuromodulation. 2025 Jun 22. doi: 10.1016/j.neurom.2025.05.005.
Deep brain stimulation (DBS) is an advanced treatment for individuals with GNAO1-related disorders (GNAO1-RD), which are characterized by severe movement abnormalities such as status dystonicus and dyskinetic crises. Decision-making surrounding DBS is complex and influenced by medical, emotional, and logistical factors. This study aimed to explore caregiver perspectives on the decision-making process, including influencing factors and family experiences.
A European Union survey was administered to caregivers of individuals with genetically confirmed GNAO1-RD who had undergone DBS. The survey collected data on demographics, clinical features, decision-making factors, and postoperative experiences. Quantitative data were descriptively analyzed whereas qualitative data were thematically analyzed.
Twelve caregivers from ten countries participated, with individuals who underwent DBS at a median age of 10.69 years and follow-up durations ranging from <1 to 8.9 years. The primary indication was the management of status dystonicus and dyskinetic crises (9/12). The decision was categorized as urgent in nine of 12 cases. Factors influencing the decision included long-term quality of life, DBS effectiveness, prevention of hospitalizations, and surgeon expertise. Postoperatively, eight of 12 families reported significant reductions in status dystonicus and dyskinetic crises, with improvements observed within days to months. Challenges included inadequate preoperative information, rushed decisions due to medical urgency, and emotional tolls.
DBS is perceived by caregivers as a life-saving intervention for GNAO1-RD, effectively reducing dyskinetic crises and status dystonicus while improving quality of life. DBS decision-making is highly complex and emotionally taxing. Enhanced communication, evidence-based guidance, and caregiver support are critical to empowering families during this process.
脑深部电刺激术(DBS)是治疗与GNAO1相关疾病(GNAO1-RD)患者的一种先进疗法,这些疾病的特征是严重的运动异常,如张力障碍状态和运动障碍危象。围绕DBS的决策很复杂,受到医学、情感和后勤因素的影响。本研究旨在探讨照料者对决策过程的看法,包括影响因素和家庭经历。
对基因确诊为GNAO1-RD且接受过DBS治疗的患者的照料者进行了一项欧盟调查。该调查收集了有关人口统计学、临床特征、决策因素和术后经历的数据。对定量数据进行描述性分析,对定性数据进行主题分析。
来自10个国家的12名照料者参与了研究,接受DBS治疗的患者中位年龄为10.69岁,随访时间从不到1年到8.9年不等。主要适应症是治疗张力障碍状态和运动障碍危象(9/12)。12例中有9例的决策被归类为紧急。影响决策的因素包括长期生活质量、DBS的有效性、预防住院以及外科医生的专业知识。术后,12个家庭中有8个报告张力障碍状态和运动障碍危象显著减轻,在数天至数月内有改善。挑战包括术前信息不足、由于医疗紧急情况而仓促做出的决策以及情感负担。
照料者认为DBS是治疗GNAO1-RD的一种挽救生命的干预措施,可有效减少运动障碍危象和张力障碍状态,同时提高生活质量。DBS决策非常复杂且在情感上令人疲惫。加强沟通、循证指导和照料者支持对于在此过程中增强家庭能力至关重要。